Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor-positive Breast Cancer.

Robert B Jones Jonathan Farhi Miranda Adams Kiran K Parwani Garrett W Cooper Milica Zecevic Richard Sean Lee Andrew L Hong Jennifer Marie Spangle

Published in: Cancer research communications (2022)

breast cancer may derive clinical benefit from combined PI3K/MLL inhibition.

Keyphrases